NASDAQ •
Healthcare •
Medical Devices •
Quote as of 07/10/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization42 mln
Float26.05 mln
Earnings Date08/12/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
5.68
Highly suspicious
Relative Strength
61
/ 100
Outperforming
Debt / Equity
0.19
Very low leverage
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Elutia Inc. is a Maryland-based medical company that makes specialized biological tissue products designed to support surgical repair in two main areas: women's health and heart surgery. Their product lineup includes materials used to reconstruct soft tissue, repair heart defects, support cardiac structures in newborns and infants, and restore blood vessels. The company is also advancing a new generation of products that combine biological scaffolds with built-in antibiotic delivery to help reduce the risk of infection after surgery. Elutia sells directly to hospitals and healthcare facilities through independent sales agents, and was previously known as Aziyo Biologics Inc. before rebranding in 2023.
